These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3891675)

  • 61. The nature and the management of schizophrenia.
    Johnstone EC
    Scott Med J; 1991 Feb; 36(1):4-5. PubMed ID: 2031171
    [No Abstract]   [Full Text] [Related]  

  • 62. Bilateral ballism induced by ibuprofen in a schizophrenic patient.
    Sandyk R; Awerbuch G; Rapcsak SZ
    Postgrad Med J; 1987 Jul; 63(741):593. PubMed ID: 3658874
    [No Abstract]   [Full Text] [Related]  

  • 63. Neurotransmitters and CNS disease. Schizophrenia.
    Snyder SH
    Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
    [No Abstract]   [Full Text] [Related]  

  • 64. The neuropathology of schizophrenia.
    Stevens JR
    Psychol Med; 1982 Nov; 12(4):695-700. PubMed ID: 7156246
    [No Abstract]   [Full Text] [Related]  

  • 65. Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain.
    Sedvall CG; Farde L; Hall H; Halldin C; Karlsson P; Brene S; Lindefors N; Persson H; Chipkin RE; Ehrlich M
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():466A-467A. PubMed ID: 1386781
    [No Abstract]   [Full Text] [Related]  

  • 66. The biochemistry of schizophrenia--a review.
    Shelley RK; Walsh N
    Ir Med J; 1985 May; 78(5):139-43. PubMed ID: 3891675
    [No Abstract]   [Full Text] [Related]  

  • 67. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
    [No Abstract]   [Full Text] [Related]  

  • 68. CT scans in schizophrenia.
    Reveley MA
    Br J Psychiatry; 1985 Apr; 146():367-71. PubMed ID: 3893596
    [No Abstract]   [Full Text] [Related]  

  • 69. [Brain imaging in schizophrenia -- especially by Computed Tomography].
    Szulc A
    Psychiatr Pol; 1994; 28(2):145-56. PubMed ID: 8208861
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
    List SJ; Cleghorn JM
    Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How schizophrenia develops: new evidence and new ideas.
    Harv Ment Health Lett; 2001 Feb; 17(8):1-4. PubMed ID: 11175456
    [No Abstract]   [Full Text] [Related]  

  • 72. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 73. Chemical brain anatomy in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1995 Sep; 346(8977):743-9. PubMed ID: 7658878
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.